Search

Author/Creator Butler, Marcus O.

1. Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria. (September 2022)

Authors:
Larkin, James; Weber, Jeffrey; Del Vecchio, Michele; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cowey, C. Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O.; Di Giacomo, Anna Marie; Middleton, Mark R.; De la Cruz-Merino, Luis; Arenberg...
Journal:
European journal of cancer
Issue:
Volume 173(2022)
Page Start:
285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Issue 3 (26th September 2022)

Authors:
Weber, Jeffrey S.; Schadendorf, Dirk; Del Vecchio, Michele; Larkin, James; Atkinson, Victoria; Schenker, Michael; Pigozzo, Jacopo; Gogas, Helen; Dalle, Stéphane; Meyer, Nicolas; Ascierto, Paolo A.; Sandhu, Shahneen; Eigentler, Thomas; Gutzmer, Ralf; Hassel, Jessica C.; Robert, Caroline; Carlino, ...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 3(2023)
Page Start:
517
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE). Issue 1 (13th March 2019)

Authors:
Clouthier, Derek L.; Lien, Scott C.; Yang, S. Y. Cindy; Nguyen, Linh T.; Manem, Venkata S. K.; Gray, Diana; Ryczko, Michael; Razak, Albiruni R. A.; Lewin, Jeremy; Lheureux, Stephanie; Colombo, Ilaria; Bedard, Philippe L.; Cescon, David; Spreafico, Anna; Butler, Marcus O.; Hansen, Aaron R.; Jang, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells. (February 2019)

Authors:
Kagoya, Yuki; Saijo, Hiroshi; Matsunaga, Yukiko; Guo, Tingxi; Saso, Kayoko; Anczurowski, Mark; Wang, Chung-Hsi; Sugata, Kenji; Murata, Kenji; Butler, Marcus O.; Arrowsmith, Cheryl H.; Hirano, Naoto
Journal:
Journal of autoimmunity
Issue:
Volume 97(2019)
Page Start:
10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Cancer patients' experiences with immune checkpoint modulators: A qualitative study. (2nd March 2020)

Authors:
Ala‐Leppilampi, Kari; Baker, Natalie A.; McKillop, Chris; Butler, Marcus O.; Siu, Lillian L.; Spreafico, Anna; Abdul Razak, Albiruni R.; Joshua, Anthony M.; Hogg, David; Bedard, Philippe L.; Leighl, Natasha; Oza, Amit M.; Parsons, Janet A.; Hansen, Aaron R.
Journal:
Cancer medicine
Issue:
Volume 9:Number 9(2020)
Page Start:
3015
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Chaperones of the class I peptide-loading complex facilitate the constitutive presentation of endogenous antigens on HLA-DP84GGPM87. (August 2019)

Authors:
Anczurowski, Mark; Sugata, Kenji; Matsunaga, Yukiko; Yamashita, Yuki; Wang, Chung-Hsi; Guo, Tingxi; Murata, Kenji; Saijo, Hiroshi; Kagoya, Yuki; Saso, Kayoko; Butler, Marcus O.; Hirano, Naoto
Journal:
Journal of autoimmunity
Issue:
Volume 102(2019)
Page Start:
114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Development of the Functional Assessment of Cancer Therapy–Immune Checkpoint Modulator (FACT‐ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs. Issue 7 (8th January 2020)

Authors:
Hansen, Aaron R.; Ala‐Leppilampi, Kari; McKillop, Chris; Siu, Lillian L.; Bedard, Philippe L.; Abdul Razak, Albiruni R.; Spreafico, Anna; Sridhar, Srikala S.; Leighl, Natasha; Butler, Marcus O.; Hogg, David; Sacher, Adrian; Oza, Amit M.; Al‐Agha, Rany; Maurice, Catherine; Chan, Christopher T.; Sh...
Journal:
Cancer
Issue:
Volume 126:Issue 7(2020)
Page Start:
1550
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma. Issue 1 (March 2022)

Authors:
Federico Paly, Victoria; Kurt, Murat; Zhang, Lirong; Butler, Marcus O.; Michielin, Olivier; Amadi, Adenike; Hernlund, Emma; Johnson, Helen M.; Kotapati, Srividya; Moshyk, Andriy; Borrill, John
Journal:
MDM policy & practice
Issue:
Volume 7:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗